Washington, D.C., – Cathy Peters was recognized by the American Cancer Society Cancer Action Network (ACS CAN) this week in honor of her exceptional work advocating for cancer-fighting public policies. ACS CAN presents the award to a staff person who has consistently demonstrated outstanding leadership and excellence in the
Washington, D.C., – Wisconsin was recognized as the country’s top state advocacy team by the American Cancer Society Cancer Action Network (ACS CAN) in honor of their exceptional work advocating for cancer-fighting public policies. ACS CAN presents this award to combined staff and volunteer teams that have worked together
Washington, D.C., – Greta Johnson was presented the National Professional Achievement Award by the American Cancer Society Cancer Action Network (ACS CAN) for her dedication to championing the organization’s mission to end cancer as we know it, for everyone. ACS CAN presents the award each year to a staff
MADISON, Wis. – Sara Sahli was recognized as the country’s top government relations professional by the American Cancer Society Cancer Action Network (ACS CAN) in honor of her exceptional work advocating for cancer-fighting public policies. ACS CAN presents the award to a staff person who has consistently demonstrated outstanding
Dani Hornstein was awarded Ambassador Constituent Team (ACT) Lead of the Year by the American Cancer Society Cancer Action Network (ACS CAN) for her exceptional commitment to advocacy work and making cancer a national priority.
The One Big Beautiful Bill Act (OBBRA) includes provisions requiring individuals who receive insurance coverage through the Patient Protection and Affordable Care Act (ACA) Medicaid expansion to complete at least 80 hours per month of work or other qualifying community engagement (known as “Medicaid work requirements”). The statute includes an
Governor Matt Meyer signed legislation requiring state-regulated health insurance plans, including Medicaid, in Delaware to cover medically appropriate biomarker testing, helping improve access to precision medicine that can guide treatment decisions.
